Genomics Market In-Depth Analysis, Growth Strategies and Comprehensive Forecast to 2032

 The Genomics market revenues were estimated at US$ 24.3 Billion in 2021 and is anticipated to grow at a CAGR of 19.8% from 2022-2032, according to a recently published Future Market Insights report. By the end of 2032, the market is expected to reach US$ 170.5 Billion.


Technological improvements in genetic tools and molecular diagnostics have been one of the key driving factors for genomic companies' increased investment in the industry. The scientific community has attempted to address genetic vulnerability and intensity to SARS-CoV-2 infection by combining research efforts and exploiting existing genetic databases.

Get Full Access @  https://www.futuremarketinsights.com/reports/genomics-market

Multiomic-based approaches and genome-wide association analyses have revealed biological networks and shared variants underpinning host-pathogen interactions (GWAS). Similarly, genomic data like as polygenic risk scores (PRS), ABO blood groups, and HLA haplotypes could be used to decipher COVID-19 comorbidities, resistance, and susceptibility. Biobanks that link electronic health records (EHRs) to genetic data can also be utilized to look into the role of genomic factors in SARS-CoV-2 patients' clinical histories.

Market growth is expected to be fueled by the growing demand for genomics products, which is being driven by prominent manufacturers' ongoing launches of nucleic acid extraction reagents and kits.

Genome-wide association studies are the study of the entire genetic material of an organism, including its DNA sequence, organization, function, and evolution. It is a branch of molecular biology that has emerged in recent years due to advances in DNA sequencing technologies, which have enabled researchers to study the genetic makeup of organisms more comprehensively and rapidly than ever before.

Competitive Landscape

Key players in the genomics market are purchasing smaller businesses in order to enhance their products in line with the latest innovations. Illumina, Inc., for example, acquired Bluebee in June 2020 to improve genetic analysis. Bluebee's cloud capabilities are projected to lower the costs of sharing, storing, and maintaining genetic data in new products.

The growing number of brands offering cutting-edge technology Genomics, continuous development of characteristics offering the best consumer experience and at prices suitable for different income groups, and a growing e-commerce sector all contribute to market growth.

The key players in the market include Thermo Fisher Scientific, Agilent Technologies, Beijing Genomics Institute, Bio-Rad Laboratories, Danaher Corporation, F. Hoffmann-La Roche Ltd., GE Healthcare, Illumina Inc., Oxford Nanopore Technologies, QIAGEN N.V., Myriad Genetics, Inc., Quest Diagnostics Incorporated, Eppendorf AG, and Eurofins Scientific.

Some of the recent developments of key Genomics providers are as follows:

  • In January 2020, Color Genomics, Inc., in partnership with NorthShore University HealthSystem, launched a smartphone-based clinical genomics project in routine health care.
  • In February 2020, the National Cancer Center of Japan partnered with the Foundation Medicine Corporation and Chugai Pharmaceutical, Ltd. to launch a clinical trial for the third stage of the country's cancer genomic screening collaboration.
  • In September 2020, Thermo Fisher Precision Medicine Science Center (PMSC) partnered with the University of Nebraska Medical Center (UNMC) and AstraZeneca to come up with more standard healthcare biomarker discovery solutions. This was meant to help support the standardization of various processes.
  • In December 2020, Agilent Technologies gained permission from Japan's Ministry of Health, Labour, and Welfare for its GenetiSure Dx Postnatal Assay (MHLW). Microarray analysis is used in this test. The corporation was able to sell this product in Japan after receiving this approval.

Market Segments Covered in Genomics Industry Analysis

By Application:

  • Functional Genomics
    • Real-time PCR
    • Transfection
    • SNP Analysis
    • Mutational Analysis
    • Microarray Analysis
    • RNA Interference
  • Pathway Analysis
    • Microarray Analysis
    • Bead-based Analysis
    • Proteomics Tools
    • Real-time PCR
    • Mass Spectrometry
  • Biomarker Discovery
    • DNA Sequencing
    • Microarray Analysis
    • Real-time PCR
    • Mass Spectrometry
    • Other Biomarker Discoveries
  • Epigenetics
    • Bisulfite Sequencing
    • Microarray Analysis
    • Chromatin Immunoprecipitation
    • Methylated DNA Immunoprecipitation
    • Other Epigenetics
  • Other Applications & Technologies

By Deliverable:

  • Products
  • Services

By End-use:

  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Clinics
  • Academic and Government Institutes
  • Clinical Research
  • Other End Users

Comments

Post a Comment

Popular posts from this blog

Pet Diabetes Care Devices Market Report | Size, Growth, Demand, Scope and Forecast to 2032

  The global  Pet Diabetes Care Devices Market  is expected to grow at a  6.5%  CAGR, reaching  US$ 4 billion  by 2032, up from  US$ 2 billion  in 2021. “The number of pets with diabetes, the number of adopted pets, and the number of overweight pets are all driving the market forward.” Get Full Access @ https://www.futuremarketinsights.com/reports/pet-diabetes-care-devices-market The domestication of animals is leading to a lack of insulin production in them. The limited flow of glucose to the cell can be termed diabetes. This chronic disease is a major concern for pet owners and needs to be taken care of. This concern leads to the expansion of the pet diabetes care devices market. Devices like the alphatrak blood glucose meter are in use as they help the pet owners monitor the pet’s health. The increased number of people adopting pets and then domesticating them around in their households, treating and caring for them as f...
Read more

Human Immunodeficiency Virus Type 1 (HIV 1) Market Opportunity, Competitive Analysis, Future Prospects to 2033

Image
  The global Human Immunodeficiency Virus Type 1 (HIV 1) Market is predicted to exceed a remarkable valuation of US$ 34.83 Billion in 2023, with a compound annual rate of growth (CAGR) of 6% estimated from 2023 to 2033. The Institute for Health Metrics and Evaluation attributes the industry's growth to the soaring incidence rate of HIV-1 infection, which, unlike the deaths caused from this viral illness, has not updated substantially over time. Get Full Access @ https://www.futuremarketinsights.com/reports/human-immunodeficiency-virus-type-1-hiv1-market It affected approximately 37 million people worldwide. Furthermore, antiretroviral therapeutic interventions for disease management are only available to half of this population. HIV-1 is the more common of the two types of human immunodeficiency virus, accounting for approximately 96% of all infections globally. The prevalence of HIV is rising at an alarming rate. The World Health Organization (WHO) estimates that 33.0 million...
Read more

Clostridium Diagnostics Market in US is anticipated to secure a market value worth US$ 2.7 Billion by 2032 | FMI

Image
  The global Clostridium Diagnostics Market is expected to grow at a CAGR of 12.2% during the forecast period, from US$ 2.5 billion in 2022 to US$ 7.8 billion by 2032. The market grew at a CAGR of 13.6% between 2015 and 2021. The rising prevalence of clostridium-related diseases, as well as increased campaigns to educate people about the condition, are driving the market growth. To learn more about this report @ https://www.futuremarketinsights.com/reports/clostridium-diagnostics-market here has been an increased focus of players in the market to offer vaccines, which can augment the market size in the forecast period. For instance, in March 2022, Japan launched a new center, with a budget of US$ 1.6 Billion, to support vaccine and drug projects as a part of a larger scheme to tackle infectious diseases. SCARDA will be in charge of establishing a flagship R&D site for innovative collaborations and controlling funds for R&D projects. Awareness camp...
Read more